In focus · trending topic

liver fibrosis

19 stories · following the connections

Galectin Therapeutics launches the Liver Line, an online community and publication on liver health and liver disease

By Nasdaq OMXMay 3, 2017, 12:31 PM UTC

Galectin Therapeutics launches the Liver Line, an online community and publication on liver health and liver disease

By Nasdaq OMXMay 3, 2017, 12:31 PM UTC

Galectin Therapeutics and Exalenz to Present Late-Breaking Abstract at The International Liver Congress™ 2017

By Nasdaq OMXApr 18, 2017, 12:01 PM UTC

Galectin Therapeutics and Exalenz to Present Late-Breaking Abstract at The International Liver Congress™ 2017

By Nasdaq OMXApr 18, 2017, 12:01 PM UTC

Galectin Therapeutics Reports 2016 Financial Results and Provides Business Update

By Nasdaq OMXMar 28, 2017, 12:31 PM UTC

Galectin Therapeutics Issues Statement Regarding GALTW and GALTU

By Nasdaq OMXMar 23, 2017, 12:30 PM UTC

Galectin Therapeutics to Present at BIO CEO & Investor Conference

By Nasdaq OMXFeb 8, 2017, 1:30 PM UTC

Galectin Therapeutics to Webcast Corporate Update At Annual Meeting of Stockholders

By Nasdaq OMXDec 8, 2016, 1:00 PM UTC